AC Immune
ACIU
40 hedge funds and large institutions have $63.3M invested in AC Immune in 2026 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 7 closing their positions.
73% more call options, than puts
Call options by funds: $425K | Put options by funds: $245K
8% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 12
0.3% less ownership
Funds ownership: 24.04% → 23.74% (-0.3%)
7% less funds holding
Funds holding: 43 → 40 (-3)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
44% less capital inflows, than outflows
Capital inflows: $930K | Capital outflows: $1.66M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$416K |
| 2 |
XTX Topco
George Town,
Cayman Islands
|
+$134K |
| 3 |
BlackRock
New York
|
+$109K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$46.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$46.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$983K |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$220K |
| 3 |
Morgan Stanley
New York
|
-$214K |
| 4 |
Jump Financial
Chicago,
Illinois
|
-$57.3K |
| 5 |
Verdad Advisers
Boston,
Massachusetts
|
-$38.8K |
ACIU Hedge Fund Activity: Q3 2026 in Review
40 of the 8,199 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2026, worth a combined $63.3M — up 8.7% from $58.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ACIU and 5 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 13 added.
The largest buyer was Two Sigma Investments, adding an estimated $416K. The largest seller was Millennium Management, cutting an estimated $983K.
- 40 institutional investors held AC Immune (ACIU) as of Q3 2026, down from 43 in Q2 2026.
- Funds reported $63.3M of AC Immune stock for Q3 2026, up 8.7% quarter-over-quarter.
- 5 funds opened new AC Immune positions in Q3 2026 and 7 closed out, a net change of -2 holders.
- The largest AC Immune buyer in Q3 2026 was Two Sigma Investments, an estimated $416K added.
- The largest AC Immune seller in Q3 2026 was Millennium Management, an estimated $983K sold.
Based on aggregated 13F filings for Q3 2026.